Skip to main content

Table 2 The GLS, segmental strain, and estimated LVEF% in group I and group II before and after receiving antiviral treatment at each group

From: Global longitudinal strain as a predictor of short-term effect of oral antiviral regimens on myocardium in Egyptian patients with chronic viral hepatitis C

 

Group I (n = 100)

Group II (n = 20)

Before

After

p value

Before

After

p value

LVEF%

47.69 ± 2.54

47.01 ± 2.53

0.06

63.7 ± 3.96

63.29 ± 3.91

0.089

GLS

− 13.86 ± 0.83

− 12.83 ± 0.87

0.003

− 25.09 ± 2.04

− 24.41 ± 2.05

0.039

Basal anterior

− 16.12 ± 5.8

− 15.3 ± 5.81

0.006

− 22.65 ± 3.88

− 22.01 ± 4.48

0.023

Basal anteroseptal

− 10.89 ± 3.89

− 9.83 ± 2.92

0.002

− 21.45 ± 4.26

− 20.65 ± 3.99

0.019

Basal anterolateral

− 15.32 ± 6.41

− 14.42 ± 5.1

0.006

− 22.05 ± 4.5

− 21.56 ± 4

0.033

Basal inferior

− 13.41 ± 7.26

− 12.42 ± 5.45

0.002

− 21.75 ± 5.19

− 21.25 ± 5.13

0.042

Basal inferoseptal

− 10.9 ± 5.44

− 9.28 ± 3.38

0.002

− 21.75 ± 9.32

− 21.25 ± 7.61

0.043

Basal inferolateral

− 13.89 ± 5.22

− 12.82 ± 6.25

0.001

− 22.75 ± 5.72

− 22.45 ± 7.35

0.066

Mid anterior

− 13.56 ± 5.77

− 13.27 ± 6

0.085

− 22.9 ± 5.28

− 22.45 ± 4.95

0.03

Mid anteroseptal

− 14.48 ± 6.43

− 14.11 ± 5.77

0.075

− 22.2 ± 4.29

− 21.73 ± 5.06

0.03

Mid anterolateral

− 11.34 ± 3.32

− 10.26 ± 3.3

0.001

− 20.65 ± 3.25

− 20.25 ± 4.44

0.059

Mid inferior

− 10.85 ± 5.85

− 9.95 ± 3.97

0.006

− 20.75 ± 4.28

− 20.15 ± 5.42

0.022

Mid inferoseptal

− 12.45 ± 4.14

− 11.37 ± 4.59

0.001

− 21.8 ± 4.82

− 21.22 ± 4.12

0.021

Mid inferolateral

− 11.34 ± 5.17

− 10.21 ± 4.27

0.004

− 20.15 ± 4.42

− 19.85 ± 4.49

0.062

Apical anterior

− 15.31 ± 7.19

− 14.94 ± 9.42

0.080

− 24.25 ± 4.83

− 23.65 ± 6.21

0.033

Apical septal

− 16.79 ± 5.19

− 15.93 ± 9.39

0.011

− 29.4 ± 6.17

− 28.85 ± 6.41

0.045

Apical inferior

− 16.65 ± 6.78

− 16.43 ± 8.14

0.06

− 32.1 ± 7.98

− 31.65 ± 7.07

0.016

Apical lateral

− 14.29 ± 5.74

− 13.06 ± 6.8

0.007

− 26.15 ± 6.12

− 25.45 ± 5.98

0.027

  1. LVEF% left ventricular ejection fraction percent, GLS global longitudinal strain